TC BioPharm (Holdings) plc Annual Nonoperating Income (Expense) in GBP from 2022 to 2023

Taxonomy & unit
us-gaap: GBP
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
TC BioPharm (Holdings) plc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2022 to 2023.
  • TC BioPharm (Holdings) plc Nonoperating Income (Expense) for the quarter ending March 31, 2024 was £9.06K, a 99.7% decline year-over-year.
  • TC BioPharm (Holdings) plc annual Nonoperating Income (Expense) for 2023 was £7.24M, a 20% decline from 2022.
Nonoperating Income (Expense), Annual (GBP)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 7.24M -1.81M -20% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 9.05M Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.